# Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole

> **NCT01155544** · PHASE4 · WITHDRAWN · sponsor: **Northwell Health**

## Conditions studied

- Substance Abuse
- Substance Dependence

## Interventions

- **BEHAVIORAL:** Behavioral Intervention

## Key facts

- **NCT ID:** NCT01155544
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06
- **Primary completion:** 2013-09
- **Final completion:** 2014-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Seems to have simply stopped.
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155544, "Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01155544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*